Advertisement

Topics

MorphoSys Targets 2020 Tafasitamab Launch Following Good DLBCL Data

08:57 EDT 17 May 2019 | SCRIP

Morphosys says good L-MIND Phase II data back its plan to submit a US BLA to the US Food and...

      

Related Stories

 

Original Article: MorphoSys Targets 2020 Tafasitamab Launch Following Good DLBCL Data

NEXT ARTICLE

More From BioPortfolio on "MorphoSys Targets 2020 Tafasitamab Launch Following Good DLBCL Data"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...